PWSA Blog

Important Update for the PWS Community: HERO Phase 3 Trial for ARD-101 Voluntarily Paused

We would like to share an important update from Aardvark Therapeutics. Aardvark has announced a voluntary pause of the Phase 3 HERO clinical trial, which is evaluating ARD‑101 for the treatment of hyperphagia in people with Prader‑Willi syndrome. The decision to pause the trial is based on reversible cardiac observations identified in a non-PWS, separate healthy...

Rare Disease Advocacy in the PWS Community

Rare Disease Advocacy in New Hampshire On February 19, 2026, New Hampshire’s Rare Disease Advisory Council (RDAC) participated in a legislative lunch at the New Hampshire State Capitol to raise awareness about rare diseases and share priorities on state legislative issues impacting the rare community. Proudly representing the PWS community, and showing her stripes, was Melanie...

NEW PWS Resource Available: Swallowing in PWS

We’re excited to share a new family-friendly guide: “Swallowing in Prader-Willi Syndrome.” This easy-to-understand resource helps parents and caregivers recognize signs of swallowing difficulties, understand silent aspiration, and learn practical mealtime and pill-swallowing tips to help keep children safe and healthy. From knowing when to ask for a swallow study to simple habits that can make...

Congress Passes Five-Year Reauthorization of the Rare Pediatric Disease PRV Program!

February 3, 2026 Today, the rare disease community has meaningful news to celebrate. Congress has passed legislation that includes a five-year reauthorization of the Rare Pediatric Disease Priority Review Voucher (PRV) Program, increased federal investment in rare disease research, and several additional healthcare provisions that directly impact patients and families living with rare conditions. For...

Scroll to top